These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35858889)

  • 1. Mixed venous oxygen tension is a crucial prognostic factor in pulmonary hypertension: a retrospective cohort study.
    Nagata J; Sekine A; Tanabe N; Taniguchi Y; Ishida K; Shiko Y; Sakao S; Tatsumi K; Suzuki T
    BMC Pulm Med; 2022 Jul; 22(1):282. PubMed ID: 35858889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Xu QX; Yang YH; Geng J; Zhai ZG; Gong JN; Li JF; Tang X; Wang C
    Chin Med J (Engl); 2017 Feb; 130(4):382-391. PubMed ID: 28218209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension with a low cardiac index requires a higher PaO
    Suda R; Tanabe N; Terada J; Naito A; Kasai H; Nishimura R; Sanada TJ; Sugiura T; Sakao S; Tatsumi K
    Respirology; 2020 Jan; 25(1):97-103. PubMed ID: 31099121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The oxygen kinetic effect of inhaled iloprost in pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension].
    Cui N; Yang YH; Xie WM; Ma ZH; Luo L; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):522-6. PubMed ID: 19954007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic changes by breathing hypoxic and hyperoxic gas mixtures in pulmonary arterial and chronic thromboembolic pulmonary hypertension.
    Groth A; Saxer S; Bader PR; Lichtblau M; Furian M; Schneider SR; Schwarz EI; Bloch KE; Ulrich S
    Int J Cardiol; 2018 Nov; 270():262-267. PubMed ID: 29891241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard PAH therapy improves long term survival in CTEPH patients.
    Seyfarth HJ; Halank M; Wilkens H; Schäfers HJ; Ewert R; Riedel M; Schuster E; Pankau H; Hammerschmidt S; Wirtz H
    Clin Res Cardiol; 2010 Sep; 99(9):553-6. PubMed ID: 20419456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal.
    Santos M; Gomes A; Cruz C; Rocha J; Ricardo M; Gonçalves F; Carvalho L; Vicente M; Melo A; Reis A
    Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):749-757. PubMed ID: 30144959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are pulmonary artery pulsatility indexes able to differentiate chronic pulmonary thromboembolism from pulmonary arterial hypertension? An echocardiographic and catheterization study.
    Palecek T; Jansa P; Ambroz D; Hlubocka Z; Horak J; Skvarilova M; Aschermann M; Linhart A
    Heart Vessels; 2011 Mar; 26(2):176-82. PubMed ID: 20953614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension.
    Godinas L; Sattler C; Lau EM; Jaïs X; Taniguchi Y; Jevnikar M; Weatherald J; Sitbon O; Savale L; Montani D; Simonneau G; Humbert M; Laveneziana P; Garcia G
    J Heart Lung Transplant; 2017 Nov; 36(11):1234-1242. PubMed ID: 28666570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A systemic review and meta-analysis.
    Chen X; Zhai Z; Huang K; Xie W; Wan J; Wang C
    Clin Respir J; 2018 Jun; 12(6):2065-2074. PubMed ID: 29393580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension.
    Bartenstein P; Saxer S; Appenzeller P; Lichtblau M; Schwarz EI; Ulrich S
    Respiration; 2018; 96(2):127-137. PubMed ID: 29642071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressure-Flow During Exercise Catheterization Predicts Survival in Pulmonary Hypertension.
    Hasler ED; Müller-Mottet S; Furian M; Saxer S; Huber LC; Maggiorini M; Speich R; Bloch KE; Ulrich S
    Chest; 2016 Jul; 150(1):57-67. PubMed ID: 26892603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension.
    Khirfan G; Tejwani V; Wang X; Li M; DiDonato J; Dweik RA; Smedira N; Heresi GA
    PLoS One; 2018; 13(5):e0197700. PubMed ID: 29813091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary hemodynamic and gas exchange effects of various oxygen concentrations in patients with severe pulmonary hypertension primarily affecting the pulmonary vasculature].
    Sato K; Okada O; Tanabe N; Kato K; Yasuda J; Yamamoto T; Saito M; Mori N; Kuriyama T
    Nihon Kokyuki Gakkai Zasshi; 1999 Jun; 37(6):449-57. PubMed ID: 10434543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Oxygenation in Chronic Thromboembolic Pulmonary Hypertension Using Dead Space Ratio and Intrapulmonary Shunt Ratio.
    Minatsuki S; Hatano M; Maki H; Takimoto E; Morita H; Komuro I
    Int Heart J; 2019 Sep; 60(5):1137-1141. PubMed ID: 31484878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.
    Rådegran G; Kjellström B; Ekmehag B; Larsen F; Rundqvist B; Blomquist SB; Gustafsson C; Hesselstrand R; Karlsson M; Kornhall B; Nisell M; Persson L; Ryftenius H; Selin M; Ullman B; Wall K; Wikström G; Willehadson M; Jansson K;
    Scand Cardiovasc J; 2016 Aug; 50(4):243-50. PubMed ID: 27146648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of right ventricular work and pulmonary arterial compliance on peak exercise oxygen uptake in idiopathic pulmonary arterial hypertension.
    Messina CMS; Ferreira EVM; Singh I; Fonseca AXC; Ramos RP; Nery LE; Systrom DM; Oliveira RKF; Ota-Arakaki JS
    Int J Cardiol; 2021 May; 331():230-235. PubMed ID: 33545265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry.
    Chazova IY; Martynyuk TV; Valieva ZS; Gratsianskaya SY; Aleevskaya AM; Zorin AV; Nakonechnikov SN
    Biomed Res Int; 2020; 2020():6836973. PubMed ID: 32626754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension.
    Charalampopoulos A; Gibbs JS; Davies RJ; Gin-Sing W; Murphy K; Sheares KK; Pepke-Zaba J; Jenkins DP; Howard LS
    J Appl Physiol (1985); 2016 Sep; 121(3):623-8. PubMed ID: 27418685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.